319 related articles for article (PubMed ID: 26121684)
1. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
[TBL] [Abstract][Full Text] [Related]
2. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
[TBL] [Abstract][Full Text] [Related]
3. Magnetite-nanoparticle-encapsulated pH-responsive polymeric micelle as an MRI probe for detecting acidic pathologic areas.
Gao GH; Im GH; Kim MS; Lee JW; Yang J; Jeon H; Lee JH; Lee DS
Small; 2010 Jun; 6(11):1201-4. PubMed ID: 20449849
[No Abstract] [Full Text] [Related]
4. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
[TBL] [Abstract][Full Text] [Related]
5. Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.
Zhao G; Wang J; Peng X; Li Y; Yuan X; Ma Y
Chem Asian J; 2014 Feb; 9(2):546-53. PubMed ID: 24259489
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
[TBL] [Abstract][Full Text] [Related]
7. Theranostic magnetite cluster@silica@albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents.
Maboudi SA; Shojaosadati SA; Aliakbari F; Arpanaei A
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1485-1492. PubMed ID: 30889683
[TBL] [Abstract][Full Text] [Related]
8. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
[TBL] [Abstract][Full Text] [Related]
9. Is it possible to track intracellular chitosan nanoparticles using magnetic nanoparticles as contrast agent?
Bandeira AC; de Oliveira Matos A; Evangelista BS; da Silva SM; Nagib PRA; de Moraes Crespo A; Amaral AC
Bioorg Med Chem; 2019 Jun; 27(12):2637-2643. PubMed ID: 30992203
[TBL] [Abstract][Full Text] [Related]
10. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer based theranostic nanostructures for combined chemo- and photothermal therapy of liver cancer cells in vitro.
Jędrzak A; Grześkowiak BF; Coy E; Wojnarowicz J; Szutkowski K; Jurga S; Jesionowski T; Mrówczyński R
Colloids Surf B Biointerfaces; 2019 Jan; 173():698-708. PubMed ID: 30384266
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
13. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
[TBL] [Abstract][Full Text] [Related]
15. The perspectives of using unimolecular micelles in nanodrug formulation.
Wu YL; Li Z
Ther Deliv; 2019 Jun; 10(6):333-335. PubMed ID: 31140376
[No Abstract] [Full Text] [Related]
16. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
18. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
Lin MM; Kim DK; El Haj AJ; Dobson J
IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
[TBL] [Abstract][Full Text] [Related]
19. CEST MRI trackable nanoparticle drug delivery systems.
Han Z; Liu G
Biomed Mater; 2021 Feb; 16(2):024103. PubMed ID: 33470986
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems.
Brunetti V; Bouchet LM; Strumia MC
Nanoscale; 2015 Mar; 7(9):3808-16. PubMed ID: 25566989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
